BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30842185)

  • 1. Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
    Li CC; Liang JA; Chung CY; Chen WT; Chien CR
    Anticancer Res; 2019 Mar; 39(3):1479-1484. PubMed ID: 30842185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
    Li CC; Liang JA; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy: A population-based propensity-score-matched analysis.
    Li CC; Chen CY; Chien CR
    Medicine (Baltimore); 2018 Jun; 97(22):e10928. PubMed ID: 29851829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.
    Ke TW; Liao YM; Chiang HC; Chang SC; Wang PH; Chen YY; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e234-40. PubMed ID: 24571424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
    Hsia TC; Tu CY; Chen HJ; Chen SC; Liang JA; Chen CY; Wang YC; Chien CR
    Anticancer Res; 2014 Sep; 34(9):5175-80. PubMed ID: 25202111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
    Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
    J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
    Chien CR; Chen WT; Wang HM; Ke TW; Chiang HC; Chang SC; Huang YC; Lin CH; Huang CL; Lin YC; Chen TW; Li CC; Chao KS
    Anticancer Res; 2016 Nov; 36(11):6155-6160. PubMed ID: 27793945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Liao YM; Lin CH; Chen WT; Liang JA; Li CC; Chien CR
    Anticancer Res; 2023 Dec; 43(12):5713-5722. PubMed ID: 38030192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia.
    Kuo YH; Chien YW; Chen PR; Feng CL; Li CC; Chien CR
    World J Surg Oncol; 2019 Dec; 17(1):222. PubMed ID: 31856840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
    Cushman TR; Venigalla S; Brooks ED; Lin C; Verma V
    Anticancer Res; 2018 May; 38(5):2923-2927. PubMed ID: 29715118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
    Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
    Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity.
    Wee CW; Kang HC; Wu HG; Chie EK; Choi N; Park JM; Kim JI; Huang CM; Wang JY; Ng SY; Goodman KA
    Jpn J Clin Oncol; 2018 May; 48(5):458-466. PubMed ID: 29554287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer.
    Dapper H; Rodríguez I; Münch S; Peeken JC; Borm K; Combs SE; Habermehl D
    Radiat Oncol; 2018 Dec; 13(1):237. PubMed ID: 30509284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High
    Liang JA; Kuo YC; Chao KSC; Chen WT; Ke TW; Chou SH; Li CC; Chien CR
    Anticancer Res; 2022 Feb; 42(2):1143-1150. PubMed ID: 35093918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
    Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
    Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of tomotherapy vs linear accelerator image-guided intensity-modulated radiotherapy for localized pharyngeal cancer treated with definitive concurrent chemoradiotherapy: a Taiwanese population-based propensity score-matched analysis.
    Wang YC; Li CC; Chien CR
    Br J Radiol; 2018 Jun; 91(1086):20170947. PubMed ID: 29565652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.